大脑MRI T2高强度和神经发育结果在新生儿脑病变
Rhandi Christensen1, Elysa Widjaja2, Daphne Kamino1
1Division of Neurology, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, Canada.
Pediatric research
|February 5, 2025
概括
早期大脑MRI T2高强度在新生儿脑病变中很常见,但不能预测3岁时的神经发育结果. 这一发现有助于对患有新生儿脑病变的婴儿进行神经预测.
科学领域:
- 新生儿神经学 新生儿神经学
- 儿科神经影像学 儿科神经影像学
- 发育神经科学的发展神经科学.
背景情况:
- 新生儿脑病变 (NE) 影响到期婴儿,早期大脑磁共振成像 (MRI) 对于预后至关重要.
- 早期MRI上的T2超强度是NE中经常发现的发现,但其对长期结果的预测价值需要澄清.
研究的目的:
- 调查早期大脑MRI T2高强度与诊断为NE的预产期婴儿的神经发育结果之间的关联.
- 确定T2高强度的特定模式 (扩散性,哺乳体,pon) 与3岁时的认知,语言和运动发育相关.
主要方法:
- 一项前性队列研究包括102名孕期婴儿 (≥36周月经后年龄) 患有NE,这些婴儿接受了早期大脑MRI.
- 使用Kidokoro评分和使用Barkovich评分的扩散限制来评估T2强度过高的脑MRI.
- 多变量线性回归分析检查了T2高强度得分和Bayley-III认知,语言和运动得分在3年之间的关系,控制扩散限制.
主要成果:
- 在76%的婴儿中,T2超强度是普遍存在的,在76%的婴儿中,在哺乳动物体中,在28%的婴儿中,在17%的小马中观察到扩散性.
- 无论是扩散T2超强度得分还是哺乳体T2超强度都与3年后的认知,语言或运动结果没有显著的关联,即使在调整扩散限制后也是如此.
- 此外,Pontine T2高强度也与3年后的神经发育结果无关.
结论:
- 早期大脑MRI T2高强度是新生儿脑病变的常见发现,但似乎不是3岁时神经发育结果的可靠预测指标.
- 这些发现表明,单单T2强度过高可能不会显著影响这一群体未来的认知,语言和运动发育.
- 这些结果可以帮助临床医生对患有新生儿脑病变的婴儿进行神经预测,并可能减少与成像发现相关的家长焦虑.
相关概念视频
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).


